UCB's approval spree rolls on with FDA nod for Zilbrysq, its 2nd drug for myasthenia gravis
18th October 2023 Uncategorised 0 UCB’s approval spree rolls on with FDA nod for Zilbrysq, its 2nd drug for myasthenia gravis
kdunleavy
Wed, 10/18/2023 – 11:17
More: UCB's approval spree rolls on with FDA nod for Zilbrysq, its 2nd drug for myasthenia gravis
Source: fierce